2seventy Bio Inc Stock Ownership - Who owns 2seventy Bio?

Insider buying vs selling

Have 2seventy Bio Inc insiders been buying or selling?
Jessica SnowTitle Senior Vice President of Quality and Enabling Functions2024-05-0315$4.91
Casdin Capital LLCDirector2024-03-2640,000$5.10
Casdin Capital LLCDirector2024-03-25330,000$5.07
Casdin Capital LLCDirector2024-03-22147,377$5.12
Casdin Capital LLCDirector2024-03-21300,000$4.90
Nick LeschlyPresident and CEO2024-01-051,554$3.75
Philip D. GregoryChief Scientific Officer2024-01-05795$3.75
William D. Baird IiiChief Operating Officer2024-01-051,380$3.75
William D. Baird IiiChief Operating Officer2024-01-0333,651$3.87
Philip D. GregoryChief Scientific Officer2024-01-0325,613$3.87

1 of 3

TSVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSVT insiders and whales buy or sell their stock.

TSVT Shareholders

What type of owners hold 2seventy Bio Inc stock?
Kynam Global Healthcare Master Fund LP19.67%10,111,394$48.53MInsider
Kynam Capital Management LP19.67%10,111,394$48.53MInsider
Kynam Capital Management LP11.58%5,953,825$28.58MInstitution
Morgan Stanley8.48%4,357,506$20.92MInstitution
Goldman Sachs Group Inc8.21%4,221,783$20.26MInstitution
Blackrock Inc7.60%3,905,405$18.75MInstitution
Vanguard Group Inc7.26%3,731,679$17.91MInstitution
Casdin Capital LLC6.22%3,199,223$15.36MInsider
Baker Bros Advisors LP4.86%2,497,526$11.99MInstitution
Madison Avenue Partners LP4.73%2,433,222$11.68MInstitution

1 of 3

TSVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSVT64.50%35.50%Net BuyingNet Buying
PYXS38.93%35.71%Net Selling
DSGN42.21%57.79%Net BuyingNet Buying
CDXC9.23%90.77%Net Buying
IPSC27.89%46.33%Net SellingNet Selling

2seventy Bio Stock Ownership FAQ

Who owns 2seventy Bio?

2seventy Bio (NASDAQ: TSVT) is owned by 91.00% institutional shareholders, 50.09% 2seventy Bio insiders, and 0.00% retail investors. Kynam Global Healthcare Master Fund LP is the largest individual 2seventy Bio shareholder, owning 10.11M shares representing 19.67% of the company. Kynam Global Healthcare Master Fund LP's 2seventy Bio shares are currently valued at $48.53M.

If you're new to stock investing, here's how to buy 2seventy Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.